DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 083149
The generic ingredient in PBZ is tripelennamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tripelennamine hydrochloride profile page.
Summary for 083149
Tradename: | PBZ |
Applicant: | Novartis |
Ingredient: | tripelennamine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription